Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)
799.35
-6.75 (-0.84%)
Oct 24, 2025, 3:29 PM IST
NSE:YATHARTH Revenue
Yatharth Hospital & Trauma Care Services had revenue of 2.58B INR in the quarter ending June 30, 2025, with 21.71% growth. This brings the company's revenue in the last twelve months to 9.26B, up 24.62% year-over-year. In the fiscal year ending March 31, 2025, Yatharth Hospital & Trauma Care Services had annual revenue of 8.86B with 31.55% growth.
Revenue (ttm)
9.26B
Revenue Growth
+24.62%
P/S Ratio
8.31
Revenue / Employee
1.89M
Employees
4,895
Market Cap
77.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.86B | 2.12B | 31.55% |
| Mar 31, 2024 | 6.73B | 1.51B | 28.85% |
| Mar 31, 2023 | 5.22B | 1.21B | 30.01% |
| Mar 31, 2022 | 4.02B | 1.73B | 75.74% |
| Mar 31, 2021 | 2.29B | 826.36M | 56.59% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 274.80B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |